Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( <b>AMBER</b> ): Results in the Pre-Specified Subgroup with Heart Failure
PaperCitations, authors & open-access status
Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( <b>AMBER</b> ): Results in the Pre-Specified Subgroup with Heart Failure is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 54 citations, 2020 year and hybrid oa status.
54
Citations
2020
Year
hybrid
OA Status